Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Supplier of Omeprazole Extended-Release Capsules (NSN 6505016247068)

Active

Federal

Response Deadline08/10/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract solicits suppliers to provide FDA-approved Omeprazole Extended-Release Capsules in bulk quantities that fully comply with National Stock Number NSN 6505016247068 specifications, ensuring eligibility for procurement by the Defense Logistics Agency. The product must meet all regulatory and quality standards required for use within U.S. military medical supply chains and is intended for distribution through the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. Submission deadlines are firm, with responses due by August 10, 2026, and the solicitation is structured as a subcontract under the NAICS code 325411, which pertains to pharmaceutical and biological product manufacturing. All deliveries are to be addressed to the designated place of performance in APO, ZIP 96264-2022, with no additional office address details provided. The contract is posted on the DIBBS platform and is open to qualified manufacturers capable of meeting stringent military pharmaceutical requirements.

General Info

Suppliers must provide FDA-approved Omeprazole capsules meeting NSN 6505016247068 for DOD use by August 10, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

APO, AP, 96264-2022, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 2

subcontract

Response DeadlineAug 10

Submission deadline

Response Deadline

08/10/2026, 05:00:00 PM UTCin 7 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply FDA-approved Omeprazole Extended-Release Capsules in bulk quantities meeting NSN specifications and eligible for DLA procurement.

Similar Contracts

Same NAICS industry code

MAGNESIUM SULFATE

Solicitation # SPE2DP-26-T-4456

MAGNESIUM SULFATE 495MG/5GM oral granules in 454GM bags, sold in cases of 12 bags each, is procured under contract SPE2DP-26-T-4456 for delivery to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632 with a five-day delivery window and no tolerance for quantity variance. The product is classified as a TYPE I (CODE Q) medical item with a non-extendable shelf life of 36 months and must comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. All packaging must meet commercial standards as specified in DLA’s procurement requirements, ensuring each unit is sealed in protective containers and packed in exterior shipping containers suitable for safe, low-cost transport by common carrier to the destination. Palletization and labeling must adhere to DLA’s Packaging Requirements for Procurement and the latest version of Medical Marking Standard No. 1, available through DLA Troop Support or their official website. The item is identified by NSN 6505-01-714-4975 and NDC 46122-0461-43, supplied by AMERISOURCEBERGEN DRUG CORP, and shipped via traceable methods only—parcel post is prohibited. Delivery is FOB destination with inspection and acceptance also occurring at the point of delivery, and the required delivery date is August 5, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

Manufacturing of CARD Casualty Response Documentation ToolThe contract is for the full production of a durable, field-ready medical documentation card designed to support casualty response operations, adhering strictly to the DLA Master List technical and quality standards. The product must be robust enough for frontline use under demanding conditions and capable of reliably conveying critical medical information in austere environments. Production will be executed as a subcontract under the Department of Defense’s Medical Supply Chain MD Surg FSF, with the place of performance located in WaterVliet, New York, at the ZIP code 12189-5000. The NAICS code 325411 indicates the work falls under pharmaceutical and medicine manufacturing, underscoring the precision and regulatory compliance required in materials and processes. The solicitation was posted on August 2, 2026, with a response deadline of August 10, 2026, allowing potential subcontractors a limited window to submit proposals. The contract type is explicitly labeled as a subcontract, meaning the winning party will be engaged by a prime contractor rather than directly by the government. There is no set-aside classification specified, indicating the opportunity is open to all eligible entities regardless of business size or status. While no point of contact is listed, interested parties can access additional details through the provided DIBBS link, which hosts the official request for quotation. The focus is squarely on delivering a standardized, high-integrity medical documentation tool that meets rigorous military specifications for reliability and performance.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Hydrocortisone Cream 2.5% (NSN 6505017157536)The contract entails the procurement and delivery of ten units of Hydrocortisone Cream 2.5% in one-ounce tubes, specifically designated by NSN 6505017157536, ensuring full compliance with FDA regulations and adherence to Department of Defense medical and logistical standards as defined by DLA. All products must meet stringent military medical requirements for quality, packaging, labeling, and shelf life to support operational readiness and field distribution. The solicitation is issued under a subcontract mechanism with a NAICS code of 325411, indicating pharmaceutical manufacturing, and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. Responses are due by August 10, 2026, with the opportunity posted on August 2, 2026, providing suppliers eight days to submit proposals. The place of performance and point of contact details are not specified, but delivery must fulfill the logistical needs of the Defense Logistics Agency. The contract is accessible through the DIBBS platform, and while no set-aside designation is listed, all offerings must be FDA-approved and aligned with the prescribed military medical specifications for use in deployed and garrison medical facilities.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of NSN 6505-01-719-3181 Medical or Hazardous ItemThe contract requires the supply of a commercial item identified by NSN 6505-01-719-3181, which must meet all applicable medical, packaging, and hazardous material regulations. This item is intended for use within the Department of Defense’s medical supply chain and must be delivered in full compliance with federal standards for handling and transport of sensitive medical or hazardous goods. The work is to be performed at FPO with a ZIP code of 96675, and the contract is classified as a subcontract under NAICS code 325411, indicating the manufacturing of pharmaceutical and botanical products. The solicitation was posted on August 2, 2026, with responses due by August 10, 2026, and the official interface for details can be accessed through the DLA Dibbs platform.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Sodium Chloride Injection and Medical ConsumablesThe contract seeks a supplier to provide FDA-regulated sodium chloride injection syringes and related medical consumables that comply with strict shelf-life and packaging standards required for military medical use. The items must meet regulatory and quality benchmarks to ensure safety, sterility, and operational readiness within Department of Defense healthcare systems. Performance is scheduled to be fulfilled at the WaterVliet location with zip code 12189-5000, indicating the physical delivery point for these critical medical supplies. This is a subcontract opportunity issued under the NAICS code 325411 for pharmaceutical manufacturing and was posted on August 2, 2026, with responses due by August 10, 2026. It is managed by the Medical Supply Chain Pharm FSA under the Department of Defense and is part of the broader effort to maintain reliable, high-integrity medical inventory for U.S. military operations. Suppliers must adhere to all federal medical device and pharmaceutical regulations and deliver fully compliant products to support the readiness of deployed medical teams.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PSYLLIUM HYDROPHILIC M

Solicitation # SPE2DP-26-T-4405

The contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12-gram packets, each containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per case. This product is regulated by the FDA and must be supplied with its manufacturer’s part number NDC37000-0740-87, sourced from Procter & Gamble Distributing LLC. The item has a non-extendable shelf life of 24 months and must comply with DLA’s technical and quality requirements as defined in the DLA Master List, with packaging and marking strictly governed by Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet MIL-STD-2073-1E and DLA-specific packaging requirements, ensuring secure, commercial-grade containment capable of protecting contents during transit. Delivery is FOB destination with no tolerance for quantity variance, and items must be shipped within five days of contract award using the fastest traceable means—parcel post is prohibited. The delivery address is a Navy vessel in FPO AP 96675, with specific shipping and marking instructions governed by DLA’s logistics protocols. The NSN is 6505-01-719-3181, and the contract number is SPE2DP-26-T-4405, with an original required delivery date of August 4, 2026. All bids must include the supplier and manufacturer details for FDA referral through EBS prior to award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATE

Solicitation # SPE2DP-26-T-4415

Sumatriptan Succinate Tablets, 100 mg, are supplied in a bottle of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, in compliance with USP standards. The item is regulated by the FDA and subject to strict shelf-life requirements: it has a non-extendable shelf life of 24 months as a Type I CODE M item, and must be marked according to the latest edition of Medical Marking Standard No. 1 and MIL-STD-129 for packaging and labeling. Packaging and palletization must adhere to DLA’s Packaging Requirements for Procurement and MIL-STD-2073-1E, with no tolerance for quantity variance. The contract specifies delivery FOB destination within 20 days, with inspection and acceptance occurring at the destination. The supplier is identified as MYLAN PHARMACEUTICALS INC with NDC 00378-5632-59, and the item is procured under NSN 6505-01-727-8704. Delivery is to a U.S. military address in APO AE 09094-3219, with freight originating from Ramstein, Germany. The solicitation number is SPE2DP-26-T-4415, with a required delivery date of August 4, 2026, and bid responses due by August 10, 2026. Technical and quality requirements are governed by the DLA Master List, and the contracting official must submit a referral through EBS for FDA product validation prior to award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CARD CASUALTY RESPO

Solicitation # SPE2DS-26-T-298R

The CARD CASUALTY RESPONSE DOCUMENTATION TOOL is a compact, durable card measuring 6.5 inches by 4 and 2/8 inches, constructed from card stock with a grommet and sealed in clear plastic for protection, accompanied by a 14-inch cable tie to securely fasten it to the patient. Designed for frontline responders, it captures essential data elements required for initial casualty treatment documentation. Each card includes a unique individual bar code identifier to ensure accurate tracking and record linkage. The unit of issue is singular, and the item is designated by NSN 6515-01-575-2772 with a procurement quantity of 8 units under purchase request 7017710965. Delivery is required within five days of award, with performance occurring in WaterVliet, New York, 12189-5000. The contract, issued under solicitation SPE2DS-26-T-298R, is subject to technical and quality requirements from the DLA Master List, with compliance dependent on the revision in effect at the solicitation or award date. It falls under NAICS code 325411 and is managed by the Department of Defense’s Medical Supply Chain MD Surg FSF. The item is classified as potentially containing covered defense information, and packaging must follow DLA procurement standards. Government identification must be removed from non-accepted supplies, and bidders are required to specify their source and part number. All submissions must be made prior to the response deadline of August 10, 2026, with the solicitation posted on August 2, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

HYDROCORTISONE CREA

Solicitation # SPE2DP-26-T-4438

The contract specifies the procurement of 10 units of Hydrocortisone Cream 2.5% in 1 oz tubes, manufactured by Sun Pharmaceutical Industries, Inc., with NDC number 10631-0407-01. Each unit must be packaged in compliance with the Medical Marking Standard No. 1 and MIL-STD-2073-1E, with all labeling and marking requirements strictly followed, superseding any reference to MIL-STD-129. The product is regulated by the FDA and requires a 24-month non-extendable shelf life, with storage conditions maintained at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from freezing. Delivery is required FOB destination within five days of contract award, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The shipment must be sent by the fastest traceable means, excluding parcel post, to Fort Stewart, Georgia, under the solicitation number SPE2DP-26-T-4438. Packaging must ensure safe transit via commercial carriers at the lowest cost, with each unit sealed and protected from damage. All technical and quality requirements are governed by the DLA Master List, and the contract incorporates specific DLA packaging directives including RP001 and RD003. The contract is issued under a federal procurement system with a unit of issue of EA and a total value of $10.00.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

LIDOCAINE HYDROCHLO

Solicitation # SPE2DP-26-T-4430

The contract specifies the procurement of LidoCaine Hydrochloride 2% Mucosal Jelly in single-use prefilled plastic syringes, each containing 220 mg per 11 mL, packaged in boxes of ten units. The product is a sterile topical anesthetic intended for medical use, with a non-extendable shelf life of 36 months and must comply with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards as defined in the procurement document, ensuring each unit is sealed and protected from damage, and shipped in commercial exterior containers that guarantee safe delivery at the lowest cost to the designated destination. The item is identified by NSN 6505-01-707-4169 and NDC 25021-0673-77, supplied by Sagent Pharmaceuticals, Inc., and the unit of issue is one box containing ten syringes. Delivery is required within five days FOB destination, with no variance permitted in quantity, and inspection and acceptance occur at the delivery point. The shipment is directed to USMC facilities in Palmerston, Australia, under a SOFA tariff agreement, with specific transportation and marking instructions governed by DLA procedures. The contract was issued under solicitation SPE2DP-26-T-4430, with a response deadline in August 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy McCauley listed as the primary point of contact.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PSYLLIUM HYDROPHILI

Solicitation # SPE2DP-26-T-4403

The contract is for Psyllium Hydrophilic Mucilloid in 12 gm packets, each containing 25 mg potassium and 5 mg sodium, sold in units of 30 packets per package, with a total quantity of 10 packages required. The product, identified by NSN 6505-01-719-3181 and manufacturer part number NDC37000-0740-87 from Procter & Gamble Distributing LLC, is regulated by the FDA and must comply with all applicable medical and packaging standards, including the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for this item. The product has a non-extendable shelf life of 24 months under Type I (Code M) requirements, and all packaging must meet DLA’s commercial packaging and protection standards as outlined in MIL-STD-2073-1E and RP001, ensuring secure, carrier-acceptable delivery to the destination. Delivery is required FOB destination within 79 days of contract award, with no tolerance for quantity variance, and the item must be marked and packed strictly according to specified medical and defense logistics guidelines. The contract identifies the delivery point as APO AP 96260-5479, with the final destination at Camp Carroll, Korea, and the original required delivery date is December 17, 2025. Bidders must provide the exact source and part number being offered and are subject to FDA referral through EBS prior to award. All documentation and compliance are governed by the DLA Master List of Technical and Quality Requirements in effect on the solicitation issue date, and transport arrangements must follow DLAD Proc Notes C19 and C20. The solicitation, issued under contract number SPE2DP-26-T-4403, has a response deadline of August 10, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Diabetic and Low-Sugar Nutritional ProductsThe contract involves the manufacture and delivery of specialized sugar-free and low-glycemic medical nutritionals designed specifically for diabetic patients in hospital settings across Jamaica. These products must meet stringent nutritional and medical standards to support glycemic control and overall patient health within institutional care environments. The supplier is expected to ensure consistent production quality, adherence to regulatory protocols, and reliable distribution to meet the ongoing needs of healthcare facilities under the South East Regional Health Authority. This subcontract is issued under the NAICS code 325411, indicating it pertains to pharmaceutical and medicine manufacturing, and is administered by the Government of Jamaica through its health authority. The solicitation was posted on July 30, 2026, and the performance location is tied to the health authority’s operational network, though specific delivery sites are not detailed. While the contract does not specify a set-aside designation or point of contact, interested parties must navigate the official ePPS portal linked in the notice to access full procurement details and submit proposals in compliance with government procurement guidelines.

South East Regional Health Authority

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

GABAPENTIN CAPSULES

Solicitation # SPE2DP-26-T-4457

GABAPENTIN CAPSULES, 100 MG in units of 100s, are procured under solicitation SPE2DP-26-T-4457 with a total requirement of 7,000 capsules across two line items, each with a 0% quantity variance. The item is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including shelf-life specifications of 36 months non-extendable for TYPE I (CODE Q) items. Packaging must meet Commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with all labeling and palletization aligned to RP001 and DLA packaging directives. Storage must maintain 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) per USP Controlled Room Temperature. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, though DLA requirements override any conflicting standards. Delivery is FOB destination with a five-day lead time and inspection and acceptance occurring at the destination point. The items are to be shipped via traceable means, not parcel post, to the USS MAKIN ISLAND LHD 8 at FPO AP 96672, with a required delivery date of April 3, 2026. Manufacturers include MARLEX PHARMACEUTICALS INC, CIPLA USA INC, and SCIEGEN PHARMACEUTICALS INC, identified by their respective NDC codes. The unit of issue is BT (100s), with each unit pack containing one BT. All packaging and marking must reflect the correct NSN 6505013871892, and vendors must use the DLA VSM system for shipment tracking. Government use codes and contract identifiers are specified for administrative and logistical tracking, and all documentation must adhere to the latest DLA procedural notes for transportation, marking, and delivery verification.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

TOLNAFTATE POWDER, U

Solicitation # SPE2DP-26-T-4452

The contract specifies the procurement of Tolnaftate Powder, USP 1%, in 45-gram units, with a total quantity of 19 BT (each BT equaling 45 grams), supplied by Geri-Care Pharmaceuticals Corp. under part number NDC57896-0199-45 and NSN 6505014807897. Delivery is required within five days FOB destination, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The product must comply with strict packaging and marking standards, including Medical Marking Standard No. 1, which replaces all references to MIL-STD-129, and must be packed in sealed unit containers and commercial shipping containers ensuring safe transport at the lowest carrier rate. The item is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months. All packaging and labeling must adhere to DLA requirements outlined in the Master List of Technical and Quality Requirements, and covered defense information protocols apply. The solicitation, issued under SPE2DP-26-T-4452 with a response deadline of August 10, 2026, is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with point of contact Imerah Burnett at Offutt AFB, and the unit of issue follows DoD authorization with corresponding ANSI X12 alignment.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

LIDOCAINE HYDROCHLORID

Solicitation # SPE2DP-26-T-4454

Lidocaine hydrochloride and dextrose injection in 500 mL premixed bags, containing 0.4% lidocaine and 5% dextrose, is being procured under solicitation SPE2DP-26-T-4454 with a unit of issue defined as a package of 18 bags. The item must meet stringent technical and quality standards outlined in the DLA Master List of Technical and Quality Requirements, and packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. At least 16 months of shelf life must remain at the time of delivery to the first government activity, as the product has a fixed 18-month non-extendable shelf life under Type I (Code K) requirements. The drug is regulated by the FDA, and contractors must ensure full compliance with all applicable federal standards for commercial packaging, including ASTM D3951 where applicable, though DLA requirements take precedence. The product is currently in limited supply due to manufacturing constraints, and only Baxter Healthcare Corp’s specific NDC 00338-0409-03 and part number 2B0973P are authorized. Delivery is required within five days of award, FOB destination, with zero variance permitted in quantity. The shipment must be sent via traceable and expedited means to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632, using RDD 777 and VSM logistics protocols, and parcel post is strictly prohibited. Packaging must be palletized according to RP001 requirements and labeled in full compliance with DLA’s medical marking standards. The contract specifies a single purchase request quantity of one package, with a required delivery date of August 5, 2026, and procurement is managed by the Department of Defense’s Medical Supply Chain PHARM FSA. All bidders must provide detailed manufacturer and product information for FDA verification through EBS referral prior to award.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

SODIUM CHLORIDE IRRIGA

Solicitation # SPE2DP-26-T-4449

Sodium Chloride Irrigation, USP, is prescribed as a 0.9% solution in 250 mL plastic squeeze bottles, packaged 24 bottles per packing group, and must be stored at controlled room temperature of 25 degrees Celsius with protection from excessive heat. The product must comply with the DLA Master List of Technical and Quality Requirements, and its shelf life is fixed at 36 months without extension, classified as a Type I (Code Q) item. All packaging and labeling must adhere strictly to Medical Marking Standard No. 1, superseding MIL-STD-129, with documentation available via DLA Troop Support. Each unit must be sealed and protected from damage, and shipped in commercial exterior containers suitable for safe delivery by common carrier at the lowest cost to the designated destination. The item is identified by NSN 6505-01-253-8150 and NDC 00338-0048-02, supplied by Baxter Healthcare Corp, and is subject to a firm fixed price with zero variance allowed in quantity. Delivery is required FOB destination within five days of contract award, with inspection and acceptance occurring at the point of delivery. The contract is issued under solicitation SPE2DP-26-T-4449, with a response deadline of August 10, 2026, and falls under NAICS code 325412 for pharmaceutical preparation manufacturing. All data, including point of contact James Foggie and delivery location at Fort Bragg, NC, is governed by Federal procurement standards under the Department of Defense.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

BISMUTH SUBSALICYLA

Solicitation # SPE2DP-26-T-4459

The contract pertains to the procurement of Bismuth Subsalicylate Suspension, 262 mg per 15 mL, in 240 mL bottles, with a total order of two bottles. The item has a non-extendable shelf life of 24 months, and no more than 85 percent of that shelf life may have elapsed between the date of manufacture and the date of delivery to the government. Packaging must comply with commercial standards and meet the requirements of Medical Marking Standard No. 1, which supersedes MIL-STD-129; each unit must be sealed in a container that protects against damage, and all shipping containers must ensure safe, cost-effective delivery via common carrier to the designated destination. The product is regulated by the FDA and requires referral through EBS for confirmation by a product specialist, including full manufacturer and bidder details. Labeling, marking, and packaging must adhere strictly to the latest edition of Medical Marking Standard No. 1, accessible via the DLA website. Delivery is FOB destination within 20 days of contract award, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505015056483, NDC 00536-1286-36, and is sourced from The Harvard Drug Group, L.L.C. under solicitation SPE2DP-26-T-4459, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with performance at Fort Drum, NY.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-26-T-4455

The contract specifies the procurement of 20 packages of Artificial Tears Solution, each package containing 30 single-dose vials of 0.3 mL, for a total of 600 vials. The item is regulated by the FDA and has a non-extendable shelf life of 24 months, adhering to RS001 for TYPE I (CODE M) items. Packaging must comply with the Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be hermetically sealed and protected against damage, packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost. The product, manufactured by Allergan Inc with NDC 00023-4554-30, must be labeled and marked per DLA specifications and is not considered hazardous under Fed-Std-313, requiring commercial packaging consistent with ASTM D3951 unless superseded by higher-priority DLA technical requirements. Delivery is FOB destination within five days of order, with zero tolerance for quantity variance, and must be shipped by traceable means—parcel post is prohibited. The shipment is destined for USS THEODORE ROOSEVELT CVN 71, FPO AP 96632, with a required delivery date of August 5, 2026, and must include all applicable DLA packaging and labeling standards including palletization per RP001. The contracting official must submit an EBS referral for FDA confirmation, including manufacturer and product details.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

LIDOCAINE HYDROCHLORID

Solicitation # SPE2DP-26-T-4451

This contract specifies the procurement of 2 units of Lidocaine Hydrochloride and Epinephrine Injection, USP, each unit containing 50 cartridges of 1.7 mL with a concentration of 2% Lidocaine Hydrochloride and a 1:100,000 ratio of Epinephrine. The product is designated for local dental anesthesia via nerve block or infiltration only, must be stored at controlled room temperature below 25°C, protected from light, and must not be permitted to freeze. The item is latex-free and regulated by the FDA. A minimum of 13 months of remaining shelf life is required upon receipt by the first government activity, with a total shelf life of 15 months that is non-extendable. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be suitable for commercial shipping with protection against damage and breakage. Packaging must conform to ASTM D3951 unless otherwise overridden by DLA’s Master List of Technical and Quality Requirements, and hazardous material protocols under FED-STD-313 must be followed if applicable. Units are packed as 50 cartridges per unit of issue (PG), and palletization must meet DLA’s procurement packaging standards. Delivery is required FOB destination within 20 days of contract award to Joint Base Charleston, SC, and must be shipped via traceable logistics—parcel post is prohibited. The contract is issued under solicitation SPE2DP-26-T-4451 with a response deadline of August 10, 2026, and the item’s NSN is 6505-01-597-1328. Approved manufacturers include Henry Schein, Inc., Benco Dental Supply Co., and Darby Dental Supply, LLC, with specific part and NDC numbers listed. All documentation and labeling must strictly adhere to DLA requirements and FDA regulations.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

CYCLOSPORINE OPHTHA

Solicitation # SPE2DP-26-T-4453

Cyclosporine Ophthalmic Ointment, 0.2% per gram, in a 3.5 gram sterile, preservative-free tube, is designated for veterinary use in managing keratoconjunctivitis sicca in dogs. The unit of issue is a package containing six tubes, and the product must be stored at controlled room temperature. It is subject to strict packaging standards per the latest Medical Marking Standard No. 1 and requires marking in accordance with MMS No. 1B dated 30 March 2017. The item has a non-extendable shelf life of 24 months under RS016 compliance. The product is supplied by multiple manufacturers including Merck Sharp & Dohme LLC, Patterson Veterinary Supply, Inc., and Penn Veterinary Supply Inc., each with their respective part numbers and NDC codes. This item is procured under the Department of Defense with NSN 6509-01-530-4765 and purchase request 7017723033, with a contract solicitation number SPE2DP-26-T-4453. Delivery is scheduled for 89 days after award, FOB destination, with zero variance permitted in quantity, and inspection and acceptance occur at the destination. Packaging must meet MIL-STD-2073-1E specifications, and defense information handling requirements apply. The point of contact for the solicitation is Shairy M. Cartagena at the Medical Supply Chain Pharm FSA under the DLA.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

WATER PURIFICATION TAB

Solicitation # SPE2DP-26-T-4448

The contract specifies the procurement of 200 units of water purification tablets containing stabilized chlorine dioxide, with no active chlorine or iodine, designed for military use in first aid kits. Each unit, designated as PG, contains ten individually sealed tablets and must meet a strict 60-month shelf life, with at least 51 months remaining upon delivery to the government. The product, identified by NSN 6850-01-530-3396 and part number 8014821 from KATADYN NORTH AMERICA INC., is subject to the Hazard Communication Standard as revised under OSHA’s alignment with the Globally Harmonized System, requiring suppliers to submit approved Safety Data Sheets and compliant labels prior to award, along with employee training on updated hazard communication protocols. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and comply with MIL-STD-2073-1E for protective sealing and shipping containers suitable for common carrier transport at the lowest cost to the destination point of APO with ZIP 96260-5479. Delivery is required within 84 days FOB destination, with zero tolerance for quantity variance, and inspection and acceptance occur at the point of delivery. The item is classified as a TYPE I (CODE S) under shelf-life requirement RS001, which prohibits extension beyond the 60-month limit. All technical and quality requirements referenced are governed by the DLA Master List, and the solicitation number SPE2DP-26-T-4448 governs procurement terms under a federal acquisition vehicle.

All Other Miscellaneous Chemical Product and Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

WATER FOR IRRIGATION, S

Solicitation # SPE2DP-26-T-4458

Water for Irrigation, Sterile, USP, is a sterile, distilled, nonpyrogenic solution intended exclusively for irrigation, washing, rinsing, and dilution purposes and is not for injection by any parenteral route. Each unit is a 1000 mL semi-rigid plastic container with a screw cap, available with or without a hanging device, and is packaged in cases of 12 units per package, the unit of issue. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat, and has a non-extendable shelf life of 36 months. It is regulated by the FDA and must be marked in compliance with the latest edition of Medical Marking Standard No. 1 and labeled according to MIL-STD-129. Packaging must adhere to DLA’s RP001 requirements and ASTM D3951 for non-hazardous materials, with DLA’s technical and quality requirements overriding any conflicting standards. The item is identified by NSN 6505-01-075-0679 and NDC 00338-0004-04, manufactured by Baxter Healthcare Corporation. The contract specifies delivery of two packages totaling 24 units, with delivery due within 20 days to two separate destinations: USS William P Lawrence DDG 110 and USS Zumwalt DDG 1000, FOB destination. Inspection and acceptance occur at the delivery point, with zero variance permitted in quantity. Shipping must use traceable transport methods, and parcel post is prohibited. All requirements, including those from the DLA Master List of Technical and Quality Requirements, must be strictly followed, and the solicitation, issued by the Department of Defense, has a response deadline of August 10, 2026, with a contract award anticipated in support of military medical supply needs.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE

RINGER'S INJECTION, LAC

Solicitation # SPE2DP-26-T-4450

RINGER’S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per package, is procured under contract SPE2DP-26-T-4450 with a delivery requirement of 20 days FOB destination. The item is regulated by the FDA and requires prior confirmation by a product specialist through EBS referral, including full bidder and manufacturer details such as B. BRAUN MEDICAL INC, part number L7500, and NDC 00264-7750-00. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier at the lowest cost. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be marked according to the latest edition of MMS NO. 1, accessible via DLA’s website. The product has a non-extendable shelf life of 30 months and must be stored at or near room temperature (25°C), with brief exposure to 40°C permitted without degradation. Inspection and acceptance occur at the destination, with zero tolerance for quantity variance. The unit of issue is one package (PG), equal to 12 units, and the NSN is 6505013306267. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date. Delivery is to Gastonia, NC, and the contracting office is under the Department of Defense’s Medical Supply Chain.

Pharmaceutical Preparation Manufacturing

POSTED

about 10 hours ago

DEADLINE